We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomarker Test to Improve Endometrial Cancer Diagnosis

By LabMedica International staff writers
Posted on 25 Mar 2024

Womb cancer, a common cancer in women, is mainly characterized by abnormal bleeding, especially after menopause. More...

While only a small fraction, 5-10%, of women experiencing such bleeding are diagnosed with womb cancer, various benign conditions like polyps and fibroids can also cause bleeding. Presently, women suspected of having womb cancer undergo a transvaginal ultrasound scan, which involves inserting a probe into the vagina to check the thickness of the womb's lining. If the lining appears thickened, further examination is done through hysteroscopy, a process where a narrow telescope equipped with a camera and light is introduced into the womb via the vagina and cervix, and sometimes a biopsy is conducted. These procedures, though thorough, are invasive and often cause discomfort, generating unnecessary stress for the majority of women who do not have the condition. Now, a simple, safe, and accurate test that identifies women with womb cancer from a sample taken from the vagina could spare many healthy women from unnecessary invasive tests.

Clinician scientists from the University of Manchester (Manchester, UK) have discovered a panel of five protein markers in vaginal fluid that can accurately differentiate women with womb cancer from those without the disease. This advancement has led to the development of a test boasting over 95% accuracy in identifying post-menopausal women whose bleeding stems from cancer, surpassing the accuracy of existing diagnostic methods. The new test raises hopes for enhancing womb cancer diagnosis and reducing reliance on the current, more invasive, and anxiety-inducing hospital procedures like hysteroscopy.

During the study, samples were collected from post-menopausal women presenting symptoms, including 53 diagnosed with endometrial cancer and 65 without. The research utilized SWATH-MS, an advanced mass spectrometry technique that calculates molecular masses to reveal their composition and structure. This approach allowed for the meticulous analysis of molecules and the creation of digital protein maps from the samples. Utilizing machine learning, the researchers identified the proteins that differed significantly between the samples, leading to the development of a simple and highly accurate diagnostic model based on proteins. Going forward, the team aims to develop clinically viable tests employing well-established methods such as ELISA or Lumipulse®, or potentially exploring new platforms like lateral flow tests for rapid point-of-care testing.

“The implications of this study are significant,” said Dr Kelechi Njoku from the from University of Manchester who led the study. “If translated into clinical practice, a non-invasive, cost-effective, and accurate detection tool could improve patient care by swiftly identifying those with womb cancer while sparing many healthy women from unnecessary invasive tests.”

Related Links:
University of Manchester


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.